Reviewed by: Harithsa Asuri, MD, MPH, CAS | BrightView Medical DirectorPublished: July 4, 2022 Updated: August12, 2026
Key Takeaways
- Methadone does not typically register on a standard opiate immunoassay. A test generally needs to specifically include methadone to detect it.
- Whether a drug test screens for methadone depends on the type of test, the testing panel, and why the test is being performed.
- When methadone is specifically tested for in urine, it can remain detectable for several days. Detection time varies based on the test, dose, duration of treatment, and individual factors.
- Some medications, including the over-the-counter antihistamine diphenhydramine, have been reported to cause false-positive results on certain methadone screening tests.
- People who take legally prescribed methadone to treat opioid use disorder may have protections under the Americans with Disabilities Act (ADA), although individual employment situations can vary.
On This Page– Which Drug Tests Actually Screen for Methadone?
– How Long Does Methadone Stay in Your System?
– Common Causes of a Methadone False Positive
– Are You Protected If Methadone Shows Up on a Work Drug Test?
– Do Methadone Treatment Programs Drug Test Patients?
– Other Medications Used to Treat Opioid Use Disorder
– Get Help for Opioid Use Disorder at BrightView Health
– Frequently Asked Questions
Methadone does not typically show up as an opiate on a standard opiate drug screen. Methadone is a synthetic opioid, and standard opiate immunoassays are generally designed to identify substances such as morphine and related compounds. Detecting methadone usually requires a separate test designed specifically for methadone or its metabolite, EDDP. That means the answer to “Does methadone show up on a drug test?” depends on what the test is designed to detect. Some workplace, legal, medical, and addiction-treatment testing programs may use broader or more targeted drug panels. Methadone is an FDA-approved medication used to treat opioid use disorder (OUD). When taken as prescribed as part of a treatment program, methadone can help prevent withdrawal symptoms and reduce cravings for other opioids.
Which Drug Tests Actually Screen for Methadone?
Not every drug test checks for the same substances. A standard opiate immunoassay does not typically detect methadone. The American Society of Addiction Medicine (ASAM) notes that methadone has negligible to no cross-reactivity with a standard opiate immunoassay and generally requires its own specific test. Current federal workplace drug-testing categories include amphetamines, cocaine, marijuana, PCP, and several opiates and opioids, but methadone is not listed as part of the standard federal testing panel. Non-federal employers may use different testing panels, so the substances included in a workplace drug test can vary. Methadone may be specifically tested for in situations such as: – An expanded or targeted workplace drug test
– Certain court-ordered or legal drug tests
– Drug testing during substance use disorder treatment
– Medical monitoring when a provider needs information about medication use
Opioid testing can be performed using urine, blood, saliva, hair, or other specimens, although urine is commonly used. The exact substances detected depend on the test that is ordered. If you are receiving medication-assisted treatment or participating in our methadone treatment program, your care team can explain how drug testing is used as part of your treatment.
How Long Does Methadone Stay in Your System?
There is no single detection window that applies to everyone. When a urine test specifically looks for methadone, ASAM references show that methadone may be detectable for several days. Depending on the testing cutoff and pattern of use, published urine detection ranges include approximately 2–4 days, with some tests detecting methadone for up to 7 days or longer. Longer detection times have also been reported among people receiving ongoing methadone treatment. Drug tests may also look for EDDP, a metabolite produced when the body processes methadone. ASAM’s detection-time references show that EDDP may remain detectable in urine for several days, including up to about seven days in one referenced testing method. Substance testedGeneral urine detection guidanceMethadoneOften several days; approximately 2–4 days in some testing methods, with longer windows possibleEDDP, a methadone metaboliteMay remain detectable for several days, including up to about 7 days in some testing methodsThese ranges are general estimates, not guarantees. Detection can vary based on factors including the dose, how long a person has been taking methadone, individual metabolism, the type of specimen being tested, and the sensitivity or cutoff used by the laboratory. A drug’s detection window also should not be confused with how long someone feels its effects. If you have questions about your medication or a drug-test result, talk with your healthcare provider or the professional responsible for interpreting the test.
Common Causes of a Methadone False Positive
Drug screening tests are useful, but an initial screening result is not always the final answer. Some rapid drug screens use immunoassays, which identify substances based on how they react with particular antibodies. Occasionally, another medication can cross-react with the test and produce what appears to be a positive methadone result. One documented example is diphenhydramine, an antihistamine found in some over-the-counter allergy and sleep medications. Research has shown that diphenhydramine can produce a false-positive methadone result with certain rapid urine immunoassays. If a methadone result is unexpected, tell the healthcare provider, testing professional, or Medical Review Officer about all prescription medications, over-the-counter medicines, and supplements you take. An unexpected screening result may be followed by more specific laboratory testing to confirm what substance is actually present. A screening result alone should not be used to assume that someone has taken methadone without a prescription.
Are You Protected If Methadone Shows Up on a Work Drug Test?
Taking methadone as prescribed to treat opioid use disorder is not the same as illegally using drugs. The U.S. Department of Justice explains that the ADA can protect people with opioid use disorder who are taking legally prescribed medications, including methadone, under the supervision of a licensed healthcare professional and who are not currently engaging in illegal drug use. The ADA also protects many people participating in supervised treatment or recovery programs from discrimination based on their OUD or treatment. However, that does not mean every employment situation has the same outcome. Employers may still maintain lawful drug-testing policies and job-related safety or qualification requirements. Federal, state, local, and industry-specific requirements can also differ. If methadone appears on a workplace drug test, be prepared to provide appropriate information about your prescription or treatment to the Medical Review Officer or other authorized professional handling the result. If you believe you have experienced employment discrimination because you take prescribed methadone or receive treatment for opioid use disorder, consider speaking with an employment attorney or contacting the appropriate government agency for guidance about your specific situation.
Do Methadone Treatment Programs Drug Test Patients?
Yes. Drug testing is a routine part of treatment in opioid treatment programs that provide methadone.Current federal standards require certified opioid treatment programs to conduct random drug testing at a frequency based on accepted clinical practice and the patient’s response to treatment, with no fewer than eight random drug tests per patient each year, while allowing for individual extenuating circumstances. Drug testing during treatment is not meant to “catch” someone or shame them. It can give the care team important information about medication adherence, other substance use, potential safety concerns, and whether the treatment plan needs to be adjusted. ASAM guidance specifically advises against responding punitively to unexpected drug-test results in opioid treatment. Instead, unexpected results may indicate that someone needs additional support, a treatment adjustment, more education, or changes to the frequency of monitoring. Being open with your treatment team about substance use or an unexpected test result can help providers make safer, more informed treatment decisions. Learn more about our approach to treatment.
Other Medications Used to Treat Opioid Use Disorder
Methadone is one of several medications used to treat opioid use disorder. Other FDA-approved options include buprenorphine and naltrexone. Buprenorphine is available in several formulations and brand names, while extended-release naltrexone is available as an injection. Each medication works differently and may be appropriate for different patients. There is no single medication that is best for everyone. The decision to begin methadone, buprenorphine, naltrexone, or another treatment approach should be made with a qualified healthcare provider after an individual assessment. Medication can also be combined with counseling, behavioral health services, case management, peer support, and other recovery services as part of a comprehensive treatment plan.
Get Help for Opioid Use Disorder at BrightView Health
Questions about methadone, drug testing, or treatment should not keep someone from asking for help. BrightView Health provides compassionate outpatient treatment for substance use disorders. Our teams work with patients to understand their individual needs and determine which treatment options and services are appropriate for them. If you are considering methadone treatment or another form of treatment for opioid use disorder, our team can explain the options available near you and what to expect when you begin care. Learn About Methadone Treatment
Frequently Asked Questions
Does methadone show up on a standard 5- or 10-panel drug test?
Not necessarily. Methadone does not typically register on a standard opiate immunoassay and usually requires a methadone-specific test. The substances included in tests marketed as “5-panel” or “10-panel” can vary, so the best way to know is to check which substances the particular panel includes.
How long does methadone stay in your system after your last dose?
Methadone can generally be detected in urine for several days when a test specifically looks for it. ASAM references include urine detection ranges of approximately 2–4 days for some tests, with longer windows possible depending on the testing method, cutoff, and pattern of use.
Can I get in trouble at work if methadone shows up on a drug test?
A methadone result does not automatically mean illegal drug use. The ADA can protect people with opioid use disorder who are taking legally prescribed methadone under medical supervision and who are not currently engaging in illegal drug use. Employment situations vary, so people with questions about their individual rights should seek qualified legal guidance.
What medications can cause a false positive for methadone?
Diphenhydramine, an antihistamine found in some over-the-counter allergy and sleep products, has been documented to cause false-positive methadone results on certain rapid urine drug screens. Confirmatory laboratory testing can help determine whether an initial positive result is accurate.
Will my methadone treatment program drug test me for other substances?
Yes. Drug testing is a normal part of care in federally certified opioid treatment programs. Testing can help providers understand substance use, monitor safety, and determine whether a treatment plan needs to be adjusted. Federal standards require random testing in OTPs, but the specific testing schedule and substances included can depend on individual circumstances and program requirements. Want to learn more? Review the trusted medical and government resources used to inform this article below.
Sources
- American Society of Addiction Medicine. Appropriate Use of Drug Testing in Clinical Addiction Medicine.
- Substance Abuse and Mental Health Services Administration. Workplace Drug Testing Resources.
- National Library of Medicine, MedlinePlus. Methadone Drug Information and Opioid Testing.
- Rogers SC, et al. Rapid urine drug screens: diphenhydramine and methadone cross-reactivity. Pediatric Emergency Care.
- U.S. Department of Justice, ADA.gov. The ADA and Opioid Use Disorder: Combating Discrimination Against People in Treatment or Recovery.
- Electronic Code of Federal Regulations. 42 CFR § 8.12, Federal Opioid Use Disorder Treatment Standards.
Author
Editor
Clinical Reviewer
